DOI: 10.1055/s-00000094

Zeitschrift für Gastroenterologie

References

Yao JC. et al.
Phase III Prospective Randomized Comparison Trial of Depot Octreotide Plus Interferon Alfa-2b Versus Depot Octreotide Plus Bevacizumab in Patients With Advanced Carcinoid Tumors: SWOG S0518.

J Clin Oncol 2017;
35: 1695-1703

Download Bibliographical Data

Search in:
Access: